Is it time for a cardiac allocation score? First results from the Eurotransplant pilot study on a survival benefit-based heart allocation

Journal of Heart and Lung Transplantation

Volumn 32, Issue 9, 2013, Pages 873-880

  Smits, Jacqueline M ^a   De Vries, Erwin ^a   De Pauw, Michel ^b   Zuckermann, Andreas ^c   Rahmel, Axel ^a   Meiser, Bruno ^d   Laufer, Guenther ^c   Reichenspurner, Hermann ^e   Strueber, Martin ^f  

^a EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Cardiac Allocation Score; Eurotransplant heart transplantation; heart allocation; transplant outcomes; waiting list mortality

Indexed keywords

BILIRUBIN; CREATININE; HEMOGLOBIN; SODIUM; URIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIAC ALLOCATION SCORE; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DONOR; FEMALE; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; PATIENT; PILOT STUDY; PRIORITY JOURNAL; SCORING SYSTEM; SODIUM BLOOD LEVEL; SURVIVAL TIME; URIC ACID BLOOD LEVEL; VENTRICULAR ASSIST DEVICE;

CARDIAC ALLOCATION SCORE; EUROTRANSPLANT; HEART ALLOCATION; HEART TRANSPLANTATION; TRANSPLANT OUTCOMES; WAITING LIST MORTALITY;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; EUROPE; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PILOT PROJECTS; PROGNOSIS; REGRESSION ANALYSIS; RESOURCE ALLOCATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; WAITING LISTS; YOUNG ADULT;

EID: 84881616646     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.03.015     Document Type: Article

References (24)

1. Eurotransplant: donation, waiting lists, and transplants. In: Oosterlee A, Rahmel A, eds. Annual Report 2010 of the Eurotransplant International Foundation. Leiden, the Netherlands: Eurotransplant International Foundation, 2010
2. J.M. Smits Actual situation in Eurotransplant regarding high urgent heart transplantation Eur J Cardiothorac Surg 42 2012 609 611
3. J.M. Smits, G.D. Nossent, and E. de Vries Evaluation of the lung allocation score in highly urgent and urgent lung transplant candidates in Eurotransplant J Heart Lung Transplant 30 2011 22 28
4. W.T. Abraham, G.C. Fonarow, and N.M. Albert Predictors of in-hospital mortality in patients hospitalized for heart failure. Insights From OPTIMIZE-HF J Am Coll Cardiol 52 2008 347 356
5. S.J. Pocock, D. Wang, and M.A. Pfeffer Predictors of mortality and morbidity in patients with chronic heart failure Eur Heart J 24 2006 65 75
6. K.D. Aaronson, J.S. Schwartz, T.M.C. Chen, K.L. Wong, J.E. Goin, and D.M. Mancini Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
7. H. Spaderna, G. Weidner, K.C. Koch, I. Kaczmarec, F.M. Wagner, J.M. Smits for the Waiting for a New Heart Study Group Medical and psychosocial predictors of mechanical circulatory support device implantation and competing outcomes in the Waiting for a New Heart Study J Heart Lung Transplant 31 2012 16 26
8. H. Spaderna, N.R. Mendell, and D. Zahn Social isolation and depression predict 12-month outcomes in the Waiting for a New Heart Study J Heart Lung Transplant 29 2010 247 254
9. W.C. Levy, D. Mozaffarian, and D.T. Linker The Seattle Heart Failure Model. Prediction of survival in heart failure Circulation 113 2005 1424 1433
10. A. Goda, P. Williams, D. Mancini, and L.H. Lund Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM) J Heart Lung Transplant 30 2011 1236 1243
11. J.M. Schaffer, J.G. Allen, and E.S. Weiss Evaluation of risk indices in continuous-flow left ventricular assist device patients Ann Thorac Surg 88 2009 1889 1896
12. J.K. Kirklin, D.C. Naftel, and R.L. Kormos The fourth INTERMACS annual report: 4000 implants and counting J Heart Lung Transplant 31 2012 117 126
13. J.B. Segovia, M. Gomez-Bueno, and P. Cobo A novel primary graft failure risk score in heart transplantation J Heart Lung Transplant 28 2009 157
14. K.N. Hong, A. Iribarne, and B. Worku Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors Ann Thorac Surg 92 2011 520 527
15. E.S. Weiss, J.G. Allen, and G.J. Arnaoutakis Creation of a quantitative recipient risk Index for Mortality Prediction After Cardiac Transplantation (IMPACT) Ann Thorac Surg 92 2011 914 922
16. F.E. Harrel Jr, K.L. Lee, and D.B. Mark Tutorial in biostatistics. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361
17. J.M. Smits, H.C. van Houwelingen, J. De Meester, G.G. Persijn, and F.H. Claas Analysis of the renal transplant waiting list. Application of a parametric competing risk method Transplantation 66 1998 1146 1153
18. A.P. Kalegeropoulos, V.V. Georgiopoulou, and G. Giamouzis Utility of the Seattle Heart Failure Model in patients with advanced heart failure J Am Coll Cardiol 53 2009 334 342
19. S.S. Gottlieb Prognostic indicators. Useful for clinical care? J Am Coll Cardiol 53 2009 343 344
20. M.J. Russo, B. Worku, and A. Iribarne Does lung allocation score maximize survival benefit from lung transplantation? J Thorac Cardiovasc Surg 141 2011 1270 1277
21. N. Moazami, B. Sun, and D. Feldman Stable patients on left ventricular assist device support have a disproportional advantage: time to re-evaluate the current UNOS policy J Heart Lung Transplant 30 2011 971 974
22. S.P. Pinney Timing isn't everything: donor heart allocation in the present LVAD era J Am Coll Cardiol 60 2012 52 53
23. T. Dardas, N.A. Mokadam, F. Pagani, K. Aaronson, and W.C. Levy Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective Organ Procurement and Transplantation Network status 1A time J Am Coll Cardiol 60 2012 36 43
24. J.J. Teuteberg, G.A. Ewald, and R.M. Adamson Risk assessment for continuous flow left ventricular assist devices: does the Destination Therapy Risk Score work? J Am Coll Cardiol 60 2012 44 51